Baidu
map

爱创新更爱孩子 退休医生研发儿童感冒综合治疗仪

2018-09-27 吴慧玲 健康界

“为什么说在医院搞发明创造很难?因为懂医的不懂工科,懂工科的不懂医学,医生与技术人员在沟通上就存在很大的困难。”由于工作性质,原空军军医大学唐都医院临床试验科白杰对此深有体会。在谈话间,健康界能够感受到白杰是一位对生活和工作充满热爱和创造的人。每每讲起自己鼓捣的小发明便神采奕奕,这股精神劲儿像极了20岁出头的“小伙子”,但话说他已65岁。满腔热爱 一心为子“我是在医院搞检验的,也算是医院里摆

“为什么说在医院搞发明创造很难?因为懂医的不懂工科,懂工科的不懂医学,医生与技术人员在沟通上就存在很大的困难。”由于工作性质,原空军军医大学唐都医院临床试验科白杰对此深有体会。

在谈话间,健康界能够感受到白杰是一位对生活和工作充满热爱和创造的人。每每讲起自己鼓捣的小发明便神采奕奕,这股精神劲儿像极了20岁出头的“小伙子”,但话说他已65岁。

满腔热爱 一心为子

“我是在医院搞检验的,也算是医院里摆弄仪器是最多的。有时候仪器坏了我们自己也尝试着维修,不能老等维修人员来修。”白杰表示,正是这一过程让自己掌握了许多与机电控制相关的知识。

平日里,白杰也喜欢自己做点小发明,用他自己的话说就是,“几十年来‘搞搞停停’,一直想整出个‘完美’的仪器来。”

俗话说得好,灵感来源于生活。在工作与生活的“摩擦”中,一心热爱创造的白杰终于造出了自己的“维纳斯”——儿童型感冒综合治疗仪。

至于为什么会发明这个仪器,白杰表示,自己已经当爷爷了,今年孙子所在的幼儿园流感大爆发,致使整个幼儿园停课,家长们对此意见颇大,自己也十分为孩子的健康担忧。“我寻思着利用自己的一些技能,先研发个技术方案出来。”

“这个儿童型感冒综合治疗仪的想法已存在几十年,赶上这次流感事件,我又把这个技术整个完善了一下。”白杰表示,流感给小孩带来的痛苦太大了,而且目前也没有什么好的治疗方法,所以自己才下决心把这个项目完善好,以盼此解决小孩的安全用药问题。

其实,该项发明的成功与白杰平日里的酷爱创造、心系创新紧密相关,仪器的发明是实力使然、更是热爱使然。

“因为我刚好有此特长。本身既懂医,有会些工程学知识,不用求助于别人,就可以先出个技术方案。”

“这个三维立体绘图工具我学了有几十年的时间,是为了搞产品研发,也是因为我对产品研发有兴趣。”

“我平时喜欢看书、上网,经常自学一些东西。像法律法规、医械生产标准、国家政策我都乐于关注。”

“创新也是想为社会做点贡献,要不然自己退休在家待着也没啥意思,不如搞点自己真正喜欢的东西。”

话儿是轻描淡写的话,事儿是真正为民的事。

“发明的事情,我也专门找河南省中医院大学第二附属医院教授侯江洪做了咨询。他在儿童感冒这方面做得比较扎实,儿童型感冒综合治疗仪也得到了他的认可。这个方法确实是非常有效的治疗方式,也是中医界流传几千年的方子。”白杰如是说。

是搬运者 更是创新者

“中医外治法治疗儿童感冒及外感发热因为方法简便、毒副作用小、疗效好,易于被患儿及医生、家长接受。药浴疗法是利用预先煎好的中药药液浴洗浴人体外表的一种外治疗法。”白杰在儿童型感冒综合治疗仪的研发资料中如是写到。

白杰表示,药浴疗法既能起到物理降温作用,又可通过皮肤吸收进入人体发挥治疗作用,是小儿外感发热中应用最广的中医外治法,优势有三。

首先,儿童生理特点决定了小儿比成人更适合药浴。小儿体表面积相对较大,且肌肤娇嫩,角质层少,表皮细胞含水量丰富,肌表温度高于成人,这些都为药物透皮吸收创造了良好条件。

其次,患儿接受程度高。小儿口服药物困难,血管细小难寻,对吃药打针天生就成排斥态度,依从性差。而药浴疗法为体表用药,不须口服,也基本没有痛苦,患儿接受程度高,安全有效。

最后,经济方面有优势。药浴疗法所用的药物都是低廉的常用药、水电费不高,疗效好易于普及。

“目前,国家对儿童用药的管控趋严,针对儿童的感冒药少之又少。”白杰说,儿童感冒的发病率占儿科疾病的首位,也是万病之源,在呼吸道病毒感染中90%的患儿有发热症状。如何减轻儿童给药负担,增强儿童用药的安全有效性,是儿童感冒治疗中首先要考虑的问题。

“现在人们对绿色疗法越来越青睐有加,药浴作为中医外治的一种方法,完全符合绿色自然疗法的要求。”白杰介绍说,药浴疗法既操作简便、疗效可靠,又可有效解决儿童不愿接受打针吃药的困难,在儿科有着广阔的应用前景。

“中药是什么?就是治标治本、治急治缓相结合,所以药浴方法不但能把发烧这个事先控制下来,最主要的还是通过药物进入血管发挥治疗作用。”白杰告诉健康界,其实中药的好多药品都对感冒病毒有作用,西医在治疗感冒方面却不如中医有特色,但是让患儿去直接吃中药还是非常困难的,而药浴则不失为一种良策。

儿童型感冒综合治疗仪是白杰今年的“大动作”。据了解,白杰已经在今年3月9日申报了该项专利。

“其实这个方法并不是发明医药疗法,疗法不是我发明的,我主要发明了一个设备。”白杰把自己的发明表述为,只是在别人要过河的时候,自己发明了桥和船。“我只是协助人们把这个药浴疗法做得更完美,这个方法不是我发明出来的。”

既要低头实干 又需昂首展现

“产品越简单,则越好保护。像做CT仪器的,就需要有很多项专利保护。由于我这个仪器相对简单,我的技术线路便是唯一的技术线路。”白杰表示,自己的线路就是最佳的技术线路,没有人比他有更先进的技术线路,想把他的线路取代几乎不可能。

虽说仪器较为简单,但十万元的研发成本,也让健康界颇感惊讶。据白杰表述,此仪器的制作成本也就三万余元,但是仪器发明是个综合成本,既要包括销售、验收的花费,也要看到运输、服务、参会等各种费用。

“在发明仪器的时候,我也参考了诸多论文。像河南省中医院大学第二附属医院、湖南省中医药大学第一附属医院在儿童药浴的临床应用都较为广泛,且有很多论文发表。”白杰还说道,比如,南京中医药大学、湖南中医药大学以及河南中医药大学都发表了诸多有关小儿药浴疗法的研究论文。此外,知网中涉及药浴疗法的文章也不在少数。

白杰称,在查找论文的过程中,发现论文里的各项“指标”都是不统一的。例如,药浴处方不同、洗浴时间不同、治疗时间和观察方法也不尽相同。“用我这个仪器后,就可以把这些方面标准化,标准化了才有可能实现有效推广、大量复制、形成市场。”

其实,目前为止该仪器的制作都是白杰亲自操刀的,对其而言,仪器分为好几个部分,制作起来并非易事。“我现在先把方案整出来,再进一步实现仪器的各项功能。现在还没有正式的机型,因为我个人暂时没有投资能力,就是想通过发表论文等方式,来引起有关专家和投资者的注意。”白杰如是表示。

“投资商是追求完美的,你把专利转让给他们,他们可能很挑剔。此仪器方案虽反反复复、耗时较长,但我认为现在的方案自己很满意。”白杰说,现在仪器样机基本搞的差不多了,因为已经用专业绘图把它描绘出来了,要做出正式的样机预计两到三个月即可。

作为一位非医学专业且年逾半百的退休人员来说,此项工作确实不易。“日前,我还参加了中南六省的一个儿童学术会议,引起了许多专家和医疗器械公司的关注。此外,我还准备参加创新大赛,希望能够有更多机会面向市场,被医生、患者和投资方知晓。”

据了解,白杰已于9月8日在四川举行的首届全国精准医疗专利创新大赛中,荣获优秀项目奖。“我对这个产品很有信心,不出意外的话,我想明年大家就能见到它了。”

充满自信的白杰,采访接近尾声时不忘传授自己的“精神劲头十足”的秘诀:“生活要有规律,该睡觉的时候一定要睡觉,晚上10点~10点半之间睡觉最好,最晚拖到11点,不要没节制地玩手机,该起床也一定要起床。”

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (8)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1646867, encodeId=d1f9164686e50, content=<a href='/topic/show?id=91cfe913977' target=_blank style='color:#2F92EE;'>#综合治疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79139, encryptionId=91cfe913977, topicName=综合治疗)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=690523366225, createdName=zhaohui6739, createdTime=Wed May 08 03:49:00 CST 2019, time=2019-05-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2045813, encodeId=9b2f204581348, content=<a href='/topic/show?id=c8829465301' target=_blank style='color:#2F92EE;'>#退休医生#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=94653, encryptionId=c8829465301, topicName=退休医生)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6eba113, createdName=xiaoyeshuang, createdTime=Sun Sep 01 07:49:00 CST 2019, time=2019-09-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1285637, encodeId=a9e6128563ec3, content=<a href='/topic/show?id=77903209422' target=_blank style='color:#2F92EE;'>#创新#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32094, encryptionId=77903209422, topicName=创新)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=512a199, createdName=lilianxiang, createdTime=Sat Sep 29 13:49:00 CST 2018, time=2018-09-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1300195, encodeId=48be13001958b, content=<a href='/topic/show?id=ed5ee332423' target=_blank style='color:#2F92EE;'>#研发#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73324, encryptionId=ed5ee332423, topicName=研发)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aea0290, createdName=lqvr, createdTime=Sat Sep 29 13:49:00 CST 2018, time=2018-09-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=347038, encodeId=9f1534e03880, content=爱创新创业的医学毕业生。, beContent=null, objectType=article, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Fri Sep 28 06:55:42 CST 2018, time=2018-09-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=347002, encodeId=dbfc34e0026f, content=不错的文章值得推荐一下, beContent=null, objectType=article, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=04f22055142, createdName=131****2916, createdTime=Thu Sep 27 23:11:46 CST 2018, time=2018-09-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=346995, encodeId=1c9134699591, content=学习了,谢谢作者分享/, beContent=null, objectType=article, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3xJXLtMtt5B40XXuPjn9xn1rBhrM6fHLkX1hI86ZoWoPJkgDkZuJNKkBfBHOcRd1fAdezg7JlHNOokohdAp3WkI/0, createdBy=32c81964262, createdName=1e145228m78(暂无匿称), createdTime=Thu Sep 27 22:53:58 CST 2018, time=2018-09-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=346994, encodeId=735f346994e2, content=学习了,, beContent=null, objectType=article, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3xJXLtMtt5B40XXuPjn9xn1rBhrM6fHLkX1hI86ZoWoPJkgDkZuJNKkBfBHOcRd1fAdezg7JlHNOokohdAp3WkI/0, createdBy=32c81964262, createdName=1e145228m78(暂无匿称), createdTime=Thu Sep 27 22:53:17 CST 2018, time=2018-09-27, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1646867, encodeId=d1f9164686e50, content=<a href='/topic/show?id=91cfe913977' target=_blank style='color:#2F92EE;'>#综合治疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79139, encryptionId=91cfe913977, topicName=综合治疗)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=690523366225, createdName=zhaohui6739, createdTime=Wed May 08 03:49:00 CST 2019, time=2019-05-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2045813, encodeId=9b2f204581348, content=<a href='/topic/show?id=c8829465301' target=_blank style='color:#2F92EE;'>#退休医生#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=94653, encryptionId=c8829465301, topicName=退休医生)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6eba113, createdName=xiaoyeshuang, createdTime=Sun Sep 01 07:49:00 CST 2019, time=2019-09-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1285637, encodeId=a9e6128563ec3, content=<a href='/topic/show?id=77903209422' target=_blank style='color:#2F92EE;'>#创新#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32094, encryptionId=77903209422, topicName=创新)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=512a199, createdName=lilianxiang, createdTime=Sat Sep 29 13:49:00 CST 2018, time=2018-09-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1300195, encodeId=48be13001958b, content=<a href='/topic/show?id=ed5ee332423' target=_blank style='color:#2F92EE;'>#研发#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73324, encryptionId=ed5ee332423, topicName=研发)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aea0290, createdName=lqvr, createdTime=Sat Sep 29 13:49:00 CST 2018, time=2018-09-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=347038, encodeId=9f1534e03880, content=爱创新创业的医学毕业生。, beContent=null, objectType=article, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Fri Sep 28 06:55:42 CST 2018, time=2018-09-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=347002, encodeId=dbfc34e0026f, content=不错的文章值得推荐一下, beContent=null, objectType=article, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=04f22055142, createdName=131****2916, createdTime=Thu Sep 27 23:11:46 CST 2018, time=2018-09-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=346995, encodeId=1c9134699591, content=学习了,谢谢作者分享/, beContent=null, objectType=article, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3xJXLtMtt5B40XXuPjn9xn1rBhrM6fHLkX1hI86ZoWoPJkgDkZuJNKkBfBHOcRd1fAdezg7JlHNOokohdAp3WkI/0, createdBy=32c81964262, createdName=1e145228m78(暂无匿称), createdTime=Thu Sep 27 22:53:58 CST 2018, time=2018-09-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=346994, encodeId=735f346994e2, content=学习了,, beContent=null, objectType=article, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3xJXLtMtt5B40XXuPjn9xn1rBhrM6fHLkX1hI86ZoWoPJkgDkZuJNKkBfBHOcRd1fAdezg7JlHNOokohdAp3WkI/0, createdBy=32c81964262, createdName=1e145228m78(暂无匿称), createdTime=Thu Sep 27 22:53:17 CST 2018, time=2018-09-27, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1646867, encodeId=d1f9164686e50, content=<a href='/topic/show?id=91cfe913977' target=_blank style='color:#2F92EE;'>#综合治疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79139, encryptionId=91cfe913977, topicName=综合治疗)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=690523366225, createdName=zhaohui6739, createdTime=Wed May 08 03:49:00 CST 2019, time=2019-05-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2045813, encodeId=9b2f204581348, content=<a href='/topic/show?id=c8829465301' target=_blank style='color:#2F92EE;'>#退休医生#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=94653, encryptionId=c8829465301, topicName=退休医生)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6eba113, createdName=xiaoyeshuang, createdTime=Sun Sep 01 07:49:00 CST 2019, time=2019-09-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1285637, encodeId=a9e6128563ec3, content=<a href='/topic/show?id=77903209422' target=_blank style='color:#2F92EE;'>#创新#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32094, encryptionId=77903209422, topicName=创新)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=512a199, createdName=lilianxiang, createdTime=Sat Sep 29 13:49:00 CST 2018, time=2018-09-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1300195, encodeId=48be13001958b, content=<a href='/topic/show?id=ed5ee332423' target=_blank style='color:#2F92EE;'>#研发#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73324, encryptionId=ed5ee332423, topicName=研发)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aea0290, createdName=lqvr, createdTime=Sat Sep 29 13:49:00 CST 2018, time=2018-09-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=347038, encodeId=9f1534e03880, content=爱创新创业的医学毕业生。, beContent=null, objectType=article, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Fri Sep 28 06:55:42 CST 2018, time=2018-09-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=347002, encodeId=dbfc34e0026f, content=不错的文章值得推荐一下, beContent=null, objectType=article, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=04f22055142, createdName=131****2916, createdTime=Thu Sep 27 23:11:46 CST 2018, time=2018-09-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=346995, encodeId=1c9134699591, content=学习了,谢谢作者分享/, beContent=null, objectType=article, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3xJXLtMtt5B40XXuPjn9xn1rBhrM6fHLkX1hI86ZoWoPJkgDkZuJNKkBfBHOcRd1fAdezg7JlHNOokohdAp3WkI/0, createdBy=32c81964262, createdName=1e145228m78(暂无匿称), createdTime=Thu Sep 27 22:53:58 CST 2018, time=2018-09-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=346994, encodeId=735f346994e2, content=学习了,, beContent=null, objectType=article, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3xJXLtMtt5B40XXuPjn9xn1rBhrM6fHLkX1hI86ZoWoPJkgDkZuJNKkBfBHOcRd1fAdezg7JlHNOokohdAp3WkI/0, createdBy=32c81964262, createdName=1e145228m78(暂无匿称), createdTime=Thu Sep 27 22:53:17 CST 2018, time=2018-09-27, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1646867, encodeId=d1f9164686e50, content=<a href='/topic/show?id=91cfe913977' target=_blank style='color:#2F92EE;'>#综合治疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79139, encryptionId=91cfe913977, topicName=综合治疗)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=690523366225, createdName=zhaohui6739, createdTime=Wed May 08 03:49:00 CST 2019, time=2019-05-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2045813, encodeId=9b2f204581348, content=<a href='/topic/show?id=c8829465301' target=_blank style='color:#2F92EE;'>#退休医生#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=94653, encryptionId=c8829465301, topicName=退休医生)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6eba113, createdName=xiaoyeshuang, createdTime=Sun Sep 01 07:49:00 CST 2019, time=2019-09-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1285637, encodeId=a9e6128563ec3, content=<a href='/topic/show?id=77903209422' target=_blank style='color:#2F92EE;'>#创新#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32094, encryptionId=77903209422, topicName=创新)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=512a199, createdName=lilianxiang, createdTime=Sat Sep 29 13:49:00 CST 2018, time=2018-09-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1300195, encodeId=48be13001958b, content=<a href='/topic/show?id=ed5ee332423' target=_blank style='color:#2F92EE;'>#研发#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73324, encryptionId=ed5ee332423, topicName=研发)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aea0290, createdName=lqvr, createdTime=Sat Sep 29 13:49:00 CST 2018, time=2018-09-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=347038, encodeId=9f1534e03880, content=爱创新创业的医学毕业生。, beContent=null, objectType=article, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Fri Sep 28 06:55:42 CST 2018, time=2018-09-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=347002, encodeId=dbfc34e0026f, content=不错的文章值得推荐一下, beContent=null, objectType=article, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=04f22055142, createdName=131****2916, createdTime=Thu Sep 27 23:11:46 CST 2018, time=2018-09-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=346995, encodeId=1c9134699591, content=学习了,谢谢作者分享/, beContent=null, objectType=article, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3xJXLtMtt5B40XXuPjn9xn1rBhrM6fHLkX1hI86ZoWoPJkgDkZuJNKkBfBHOcRd1fAdezg7JlHNOokohdAp3WkI/0, createdBy=32c81964262, createdName=1e145228m78(暂无匿称), createdTime=Thu Sep 27 22:53:58 CST 2018, time=2018-09-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=346994, encodeId=735f346994e2, content=学习了,, beContent=null, objectType=article, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3xJXLtMtt5B40XXuPjn9xn1rBhrM6fHLkX1hI86ZoWoPJkgDkZuJNKkBfBHOcRd1fAdezg7JlHNOokohdAp3WkI/0, createdBy=32c81964262, createdName=1e145228m78(暂无匿称), createdTime=Thu Sep 27 22:53:17 CST 2018, time=2018-09-27, status=1, ipAttribution=)]
    2018-09-29 lqvr
  5. [GetPortalCommentsPageByObjectIdResponse(id=1646867, encodeId=d1f9164686e50, content=<a href='/topic/show?id=91cfe913977' target=_blank style='color:#2F92EE;'>#综合治疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79139, encryptionId=91cfe913977, topicName=综合治疗)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=690523366225, createdName=zhaohui6739, createdTime=Wed May 08 03:49:00 CST 2019, time=2019-05-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2045813, encodeId=9b2f204581348, content=<a href='/topic/show?id=c8829465301' target=_blank style='color:#2F92EE;'>#退休医生#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=94653, encryptionId=c8829465301, topicName=退休医生)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6eba113, createdName=xiaoyeshuang, createdTime=Sun Sep 01 07:49:00 CST 2019, time=2019-09-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1285637, encodeId=a9e6128563ec3, content=<a href='/topic/show?id=77903209422' target=_blank style='color:#2F92EE;'>#创新#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32094, encryptionId=77903209422, topicName=创新)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=512a199, createdName=lilianxiang, createdTime=Sat Sep 29 13:49:00 CST 2018, time=2018-09-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1300195, encodeId=48be13001958b, content=<a href='/topic/show?id=ed5ee332423' target=_blank style='color:#2F92EE;'>#研发#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73324, encryptionId=ed5ee332423, topicName=研发)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aea0290, createdName=lqvr, createdTime=Sat Sep 29 13:49:00 CST 2018, time=2018-09-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=347038, encodeId=9f1534e03880, content=爱创新创业的医学毕业生。, beContent=null, objectType=article, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Fri Sep 28 06:55:42 CST 2018, time=2018-09-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=347002, encodeId=dbfc34e0026f, content=不错的文章值得推荐一下, beContent=null, objectType=article, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=04f22055142, createdName=131****2916, createdTime=Thu Sep 27 23:11:46 CST 2018, time=2018-09-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=346995, encodeId=1c9134699591, content=学习了,谢谢作者分享/, beContent=null, objectType=article, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3xJXLtMtt5B40XXuPjn9xn1rBhrM6fHLkX1hI86ZoWoPJkgDkZuJNKkBfBHOcRd1fAdezg7JlHNOokohdAp3WkI/0, createdBy=32c81964262, createdName=1e145228m78(暂无匿称), createdTime=Thu Sep 27 22:53:58 CST 2018, time=2018-09-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=346994, encodeId=735f346994e2, content=学习了,, beContent=null, objectType=article, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3xJXLtMtt5B40XXuPjn9xn1rBhrM6fHLkX1hI86ZoWoPJkgDkZuJNKkBfBHOcRd1fAdezg7JlHNOokohdAp3WkI/0, createdBy=32c81964262, createdName=1e145228m78(暂无匿称), createdTime=Thu Sep 27 22:53:17 CST 2018, time=2018-09-27, status=1, ipAttribution=)]
    2018-09-28 jyzxjiangqin

    爱创新创业的医学毕业生。

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=1646867, encodeId=d1f9164686e50, content=<a href='/topic/show?id=91cfe913977' target=_blank style='color:#2F92EE;'>#综合治疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79139, encryptionId=91cfe913977, topicName=综合治疗)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=690523366225, createdName=zhaohui6739, createdTime=Wed May 08 03:49:00 CST 2019, time=2019-05-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2045813, encodeId=9b2f204581348, content=<a href='/topic/show?id=c8829465301' target=_blank style='color:#2F92EE;'>#退休医生#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=94653, encryptionId=c8829465301, topicName=退休医生)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6eba113, createdName=xiaoyeshuang, createdTime=Sun Sep 01 07:49:00 CST 2019, time=2019-09-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1285637, encodeId=a9e6128563ec3, content=<a href='/topic/show?id=77903209422' target=_blank style='color:#2F92EE;'>#创新#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32094, encryptionId=77903209422, topicName=创新)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=512a199, createdName=lilianxiang, createdTime=Sat Sep 29 13:49:00 CST 2018, time=2018-09-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1300195, encodeId=48be13001958b, content=<a href='/topic/show?id=ed5ee332423' target=_blank style='color:#2F92EE;'>#研发#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73324, encryptionId=ed5ee332423, topicName=研发)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aea0290, createdName=lqvr, createdTime=Sat Sep 29 13:49:00 CST 2018, time=2018-09-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=347038, encodeId=9f1534e03880, content=爱创新创业的医学毕业生。, beContent=null, objectType=article, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Fri Sep 28 06:55:42 CST 2018, time=2018-09-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=347002, encodeId=dbfc34e0026f, content=不错的文章值得推荐一下, beContent=null, objectType=article, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=04f22055142, createdName=131****2916, createdTime=Thu Sep 27 23:11:46 CST 2018, time=2018-09-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=346995, encodeId=1c9134699591, content=学习了,谢谢作者分享/, beContent=null, objectType=article, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3xJXLtMtt5B40XXuPjn9xn1rBhrM6fHLkX1hI86ZoWoPJkgDkZuJNKkBfBHOcRd1fAdezg7JlHNOokohdAp3WkI/0, createdBy=32c81964262, createdName=1e145228m78(暂无匿称), createdTime=Thu Sep 27 22:53:58 CST 2018, time=2018-09-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=346994, encodeId=735f346994e2, content=学习了,, beContent=null, objectType=article, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3xJXLtMtt5B40XXuPjn9xn1rBhrM6fHLkX1hI86ZoWoPJkgDkZuJNKkBfBHOcRd1fAdezg7JlHNOokohdAp3WkI/0, createdBy=32c81964262, createdName=1e145228m78(暂无匿称), createdTime=Thu Sep 27 22:53:17 CST 2018, time=2018-09-27, status=1, ipAttribution=)]
    2018-09-27 131****2916

    不错的文章值得推荐一下

    0

  7. [GetPortalCommentsPageByObjectIdResponse(id=1646867, encodeId=d1f9164686e50, content=<a href='/topic/show?id=91cfe913977' target=_blank style='color:#2F92EE;'>#综合治疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79139, encryptionId=91cfe913977, topicName=综合治疗)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=690523366225, createdName=zhaohui6739, createdTime=Wed May 08 03:49:00 CST 2019, time=2019-05-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2045813, encodeId=9b2f204581348, content=<a href='/topic/show?id=c8829465301' target=_blank style='color:#2F92EE;'>#退休医生#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=94653, encryptionId=c8829465301, topicName=退休医生)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6eba113, createdName=xiaoyeshuang, createdTime=Sun Sep 01 07:49:00 CST 2019, time=2019-09-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1285637, encodeId=a9e6128563ec3, content=<a href='/topic/show?id=77903209422' target=_blank style='color:#2F92EE;'>#创新#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32094, encryptionId=77903209422, topicName=创新)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=512a199, createdName=lilianxiang, createdTime=Sat Sep 29 13:49:00 CST 2018, time=2018-09-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1300195, encodeId=48be13001958b, content=<a href='/topic/show?id=ed5ee332423' target=_blank style='color:#2F92EE;'>#研发#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73324, encryptionId=ed5ee332423, topicName=研发)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aea0290, createdName=lqvr, createdTime=Sat Sep 29 13:49:00 CST 2018, time=2018-09-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=347038, encodeId=9f1534e03880, content=爱创新创业的医学毕业生。, beContent=null, objectType=article, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Fri Sep 28 06:55:42 CST 2018, time=2018-09-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=347002, encodeId=dbfc34e0026f, content=不错的文章值得推荐一下, beContent=null, objectType=article, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=04f22055142, createdName=131****2916, createdTime=Thu Sep 27 23:11:46 CST 2018, time=2018-09-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=346995, encodeId=1c9134699591, content=学习了,谢谢作者分享/, beContent=null, objectType=article, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3xJXLtMtt5B40XXuPjn9xn1rBhrM6fHLkX1hI86ZoWoPJkgDkZuJNKkBfBHOcRd1fAdezg7JlHNOokohdAp3WkI/0, createdBy=32c81964262, createdName=1e145228m78(暂无匿称), createdTime=Thu Sep 27 22:53:58 CST 2018, time=2018-09-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=346994, encodeId=735f346994e2, content=学习了,, beContent=null, objectType=article, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3xJXLtMtt5B40XXuPjn9xn1rBhrM6fHLkX1hI86ZoWoPJkgDkZuJNKkBfBHOcRd1fAdezg7JlHNOokohdAp3WkI/0, createdBy=32c81964262, createdName=1e145228m78(暂无匿称), createdTime=Thu Sep 27 22:53:17 CST 2018, time=2018-09-27, status=1, ipAttribution=)]
    2018-09-27 1e145228m78(暂无匿称)

    学习了,谢谢作者分享/

    0

  8. [GetPortalCommentsPageByObjectIdResponse(id=1646867, encodeId=d1f9164686e50, content=<a href='/topic/show?id=91cfe913977' target=_blank style='color:#2F92EE;'>#综合治疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79139, encryptionId=91cfe913977, topicName=综合治疗)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=690523366225, createdName=zhaohui6739, createdTime=Wed May 08 03:49:00 CST 2019, time=2019-05-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2045813, encodeId=9b2f204581348, content=<a href='/topic/show?id=c8829465301' target=_blank style='color:#2F92EE;'>#退休医生#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=94653, encryptionId=c8829465301, topicName=退休医生)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6eba113, createdName=xiaoyeshuang, createdTime=Sun Sep 01 07:49:00 CST 2019, time=2019-09-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1285637, encodeId=a9e6128563ec3, content=<a href='/topic/show?id=77903209422' target=_blank style='color:#2F92EE;'>#创新#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32094, encryptionId=77903209422, topicName=创新)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=512a199, createdName=lilianxiang, createdTime=Sat Sep 29 13:49:00 CST 2018, time=2018-09-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1300195, encodeId=48be13001958b, content=<a href='/topic/show?id=ed5ee332423' target=_blank style='color:#2F92EE;'>#研发#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73324, encryptionId=ed5ee332423, topicName=研发)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aea0290, createdName=lqvr, createdTime=Sat Sep 29 13:49:00 CST 2018, time=2018-09-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=347038, encodeId=9f1534e03880, content=爱创新创业的医学毕业生。, beContent=null, objectType=article, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Fri Sep 28 06:55:42 CST 2018, time=2018-09-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=347002, encodeId=dbfc34e0026f, content=不错的文章值得推荐一下, beContent=null, objectType=article, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=04f22055142, createdName=131****2916, createdTime=Thu Sep 27 23:11:46 CST 2018, time=2018-09-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=346995, encodeId=1c9134699591, content=学习了,谢谢作者分享/, beContent=null, objectType=article, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3xJXLtMtt5B40XXuPjn9xn1rBhrM6fHLkX1hI86ZoWoPJkgDkZuJNKkBfBHOcRd1fAdezg7JlHNOokohdAp3WkI/0, createdBy=32c81964262, createdName=1e145228m78(暂无匿称), createdTime=Thu Sep 27 22:53:58 CST 2018, time=2018-09-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=346994, encodeId=735f346994e2, content=学习了,, beContent=null, objectType=article, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3xJXLtMtt5B40XXuPjn9xn1rBhrM6fHLkX1hI86ZoWoPJkgDkZuJNKkBfBHOcRd1fAdezg7JlHNOokohdAp3WkI/0, createdBy=32c81964262, createdName=1e145228m78(暂无匿称), createdTime=Thu Sep 27 22:53:17 CST 2018, time=2018-09-27, status=1, ipAttribution=)]
    2018-09-27 1e145228m78(暂无匿称)

    学习了,

    0

相关资讯

中国药品审评审批用时进一步压缩,创新药物审评审批再提速

记者6日从全国药品监管工作座谈会上获悉,我国药品审评审批用时进一步压缩,待审评的药品注册申请已由2015年高峰时的2.2万件降至3200件以内。创新药物和医疗器械审评审批进一步加快,截至今年6月底,共对29批597件药品注册申请进行优先审评审批,审核批准了39个创新医疗器械和4个优先审批医疗器械产品。国家药品监督管理局局长焦红介绍,今年以来,通过持续深化药品医疗器械审评审批制度改革,境外新药上市明

AIWIN:迪英加科技杨林:智能点亮病理,我们始终在路上

8月25日,以“迪小骄”为名的迪英加团队经过重重比拼,最终获得评委专家一致认可,一举斩获2018世界人工智能卓医创新挑战赛的最高奖项“创新挑战奖”。

克利夫兰医学中心信息官:医院三分之一的创新来自后勤管理

如何在医疗机构培养创新文化?克利夫兰医学中心、UPMC、拉什大学医学中心高管给出了7个建议。

自主创新 中国药品和医保应坚持的发展模式

癌症已经成为威胁人类健康的“头号杀手”。目前我国每年癌症发病的约380万人,癌症死亡约230万人。

抗癌药,不只是降价这一件事——一粒药的困境如何破解?

全球每年癌症新发病例超1400万,中国2014年当年新发癌症患者已有380万例。随着癌症发病率逐年升高,患者迫切希望用上新药好药,但一粒昂贵抗癌药却几成“不可承受之痛”。抗癌药零关税、医保谈判、加快新药审批……为了让百姓顺利用上抗癌药物,国家有关部门打出“天价药”降价组合拳。随着政策红利逐一释放,患者能否如愿用上有效的抗癌药?而要从源头上解决抗癌药“入市”“天价”“断供”等诸多问题,我国的医

创新与仿制 提升抗癌药物供应保障能力

我国每年新发癌症病例超350万,死亡病例超200万……据国家癌症中心统计数据显示,癌症已成为我国严重危害健康的重大公共卫生问题之一。日前,国家卫健委有关负责人在接受人民健康采访时表示,我国正采取多项措施,提高抗癌药供应保障能力,努力满足患者用药需求。如何保证价格低廉的仿制药与进口原研药具备同等治疗效果?怎样平衡仿制与创新二者的关系?抗癌药研发进展、成果如何?对此,人民健康采访了相关部门负责人及医

Baidu
map
Baidu
map
Baidu
map